6
Participants
Start Date
August 13, 2020
Primary Completion Date
December 30, 2023
Study Completion Date
December 30, 2023
Risperidone
capsule or tablet, 0.5 mg
BioStamp nPoint device
MC10 has developed the BioStamp nPointTM, a FDA 510(k) cleared medical device. This multimodal, reusable and rechargeable biosensor uses flexible and stretchable electronics to enable unobtrusive wear on the body and monitoring in the home. The sensors have accelerometry, gyroscopy, and ECG/EMG capabilities. A docking station enables wireless recharging and data collection.
URMC Neurology; 919 Westfall Rd, Building C, Suite 100, Rochester
University of Rochester
OTHER